ArticleScientific reports2019
Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer.
Stephen Kalscheuer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it
ArticleScientific reports2019
Stephen Kalscheuer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.